Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/pharma-is-missing-the-mark-social-medias-power-proven-by-physician-influencers-302196387.html
https://www.globenewswire.com/news-release/2024/07/08/2909977/0/en/Travere-Therapeutics-to-Present-at-the-H-C-Wainwright-3rd-Annual-Kidney-Virtual-Conference.html
https://www.globenewswire.com/news-release/2024/06/11/2897202/0/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/15/2882958/0/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/09/2879252/0/en/Travere-Therapeutics-to-Present-at-National-Kidney-Foundation-Spring-Clinical-Meetings-and-the-61st-European-Renal-Association-Congress.html
https://www.globenewswire.com/news-release/2024/05/08/2878303/0/en/Travere-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/06/2876124/0/en/Travere-Therapeutics-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/29/2871667/0/en/Travere-Therapeutics-to-Report-First-Quarter-2024-Financial-Results.html
https://www.prnewswire.com/news-releases/csl-vifor-and-travere-therapeutics-announce-european-commission-approves-filspari-sparsentan-for-the-treatment-of-iga-nephropathy-302125154.html
https://www.globenewswire.com/news-release/2024/04/04/2858224/0/en/Travere-Therapeutics-to-Present-Abstracts-at-the-Society-for-Inherited-Metabolic-Disorders-and-Genetic-Metabolic-Dieticians-International.html